Latest Zydus Group News & Updates

See the latest news and media coverage for Zydus. We track all announcements, press releases, and industry mentions in real time, all in one place.

Zydus Group (Zydus)

Global pharmaceutical company

zyduslife.com

Headquarters: Ahmedabad, India
Company type: Public company
Number of employees: 20,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Zydus Group (Zydus)

In short: Zydus expanded its oncology and rare disease portfolios while navigating regulatory challenges and financial fluctuations in its wellness arm.

Company announcements

July 21 Zydus

Zydus dispatches first consignment of Zyvac TCV to UNICEF

The Typhoid Conjugate Vaccine aims to support global immunisation efforts and improve access to life-saving vaccines for communities worldwide.

May 28 Zydus

Zydus receives FDA priority review for Saroglitazar for PBC

The US FDA granted Priority Review for the NDA of Saroglitazar to treat Primary Biliary Cholangitis.

May 19 Zydus

Zydus reports 16% YoY revenue growth in Q4 FY26

Pharma business grew across regions, with EBITDA margin improving to 33.7%.

May 13 Zydus

Zydus Group to acquire Assertio Holdings

The all-cash tender offer agreement was announced between the two companies.

Media coverage

July 23 EquityPandit

Zydus Shares Slip Even as USFDA Clears Phase III Trial - Equitypandit

Zydus Lifesciences shares slipped 2% on the NSE on Thursday, even after the company cleared a big regulatory hurdle for a new drug trial.

July 23 Business Standard

Zydus receives permission for Phase III trial of Desidustat

Zydus Lifesciences has received permission to conduct a Phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted in collaboration with the...

July 21 Ad hoc news

Zydus Lifesciences stock tracks earnings and pipeline progress as profitability improves

Zydus Lifesciences stock is trading against a backdrop of improving profitability and continued investment in research and development, after the Indian pharmaceutical group (ISIN INE010B01027...

July 13 MSN

Delhi HC temporarily restricts supply of Zydus cancer drug Ikra in AbbVie patent dispute

The Delhi High Court allowed Zydus Lifesciences to continue manufacturing Ikra but temporarily barred supplies after AbbVie alleged patent infringement.

Never miss news about Zydus

Track Zydus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Zydus competitors & trending companies

Browse news for competitors to Zydus and other trending companies.